ResMed Analysts Recommendations and Consensus

RMD -- USA Stock  

USD 109.02  0.10  0.09%

The prevalent analyst and expert consensus on ResMed is Hold with 3 strong sell openions. The current projected target price consensus is 63.18 with 9 total expert opinions. On of the most common way ResMed analysists use to generate public recommendation is conference and earning calls analysis. In addition, many experts are talking to ResMed vendors, executives, and/or customers to validate their buy or sell advice.ResMed recommendation module provides average expert sentiment on the projected ResMed target price to derive its highest and lowest estimates based on target estimated volatility of 8.499. Additionally take a look at Macroaxis Advice on ResMed to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the prospective of investor risk tolerance and investment horizon.

ResMed Target Price Consensus

Number of Opinions11
Lowered Outlook0
Raized Outlook0
Hold
Macroaxis Recommendation   Exposure   Valuation

ResMed Target Price Projection

Current Price

ResMed Market Quote
Low Price108.07Odds
High Price109.21Odds

109.02

Target Price

Analyst Consensus On Target Price
Low Estimate50.0Odds
High Estimate73.1Odds
Number of Analysts9
Standard Deviation8.499

63.177

ResMed Analysit Ratings

Average Consensus

Thematic Opportunities

Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Thematic Ideas
Explore Investing Ideas  

Current Thematic Trending

Driverless Cars
Purchased over 40 shares
Traded few days ago for 62.4
Macroaxis Picks
Purchased over 30 shares
Traded few days ago for 83.93
Artificial Intelligence
Purchased over 20 shares
Traded few days ago for 101.16
Artificial Intelligence
Purchased few shares
Traded few days ago for 408.25
Impulse
Purchased over 500 shares
Traded few days ago for 5.63
Impulse
Purchased over 500 shares
Traded few days ago for 5.63
Additionally take a look at Macroaxis Advice on ResMed to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the prospective of investor risk tolerance and investment horizon. Please also try Fund Screener module to find activelly-traded funds from around the world traded on over 30 global exchanges.